|Day Low/High||35.01 / 37.24|
|52 Wk Low/High||27.55 / 50.12|
Here are my takes on stocks in biotech and other companies I own right now.
Many traders don't realize how the nature of price action has shifted.
Given broader market weakness, this is a good time to take a look at these names and develop strategies.
As long as these charts hold up, I will continue to hold them regardless of what the indices might do.
My approach to this sort of action is to forget the indices and focus on managing your individual positions.
This strength illustrates how much buying power there still is in this market.
Want another pick for this year? A recent IPO is in a good position to be a top momentum name.
My main focus is ending the year with accounts at highs and having plenty of cash on hand.
The market may need some rest and consolidation, but that doesn't mean it will produce a lot of downside.
Here are seven factors the market can be thankful for as the holiday week kicks off.
Strong markets tend to stay sticky to the upside, and the mild pressure on the indices isn't preventing some good stock picking.
There still is no compelling reason to bet on a major market correction at this time.
Meanwhile, the mighty Apple continues to provide steady support.
Stocks go higher as bump in China-trade talks turns into bounce-back, and better charts begin to emerge.
Apple seems to function as a de facto money market account these days.
Many tech stocks sporting high valuations have been selling off in recent weeks, even as the rest of the sector generally holds up well.
Plus, defense contractors remain stocks to own as geopolitical risk isn't going away.
The networking giant was reportedly willing to pay much more than $7 billion for infrastructure and app monitoring software firm Datadog, which delivered a strong IPO on Thursday.